Ajax Therapeutics Raises $40 Million
Financing led by EcoR1 Capital with additional new investor, Boxer Capital Strategic collaboration with co-founder, Schrödinger, Inc., to develop pipeline of selectively targeted therapeutics Founding...
Tag : medical clinical trials
BostonGene’s Acceptance of Abstracts to 2021 ASCO Annual Meeting
BostonGene Corporation, a biomedical software company focused on defining optimal, precision medicine-based therapies for cancer patients, today announced that two abstracts have been accepted for...
Leading mRNA Vaccine Company Moderna Announces Expansion of MTC
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced an expansion of the Moderna Technology Center (MTC) in Norwood,...
Altru Health System Powers Clinical Trial Offering with Deep Lens
VIPER™ will identify and match eligible patients to oncology clinical trials faster and with improved efficiencies across Altru Health System’s network Deep Lens and Altru...
Angie Stevens Joins Leading Digital Health Solutions Provider
Iron Bow Healthcare Solutions, a digital health solutions and global managed services provider to healthcare, commercial and government markets, today announced Angie Stevens will be...
Clinical Communication Co. Vocera to Acquire PatientSafe Solutions
Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today announced it is acquiring PatientSafe Solutions based in San Diego, CA. PatientSafe...
ZYUS Launches HOPE Phase 1 First in Human Clinical Trials
Phase 1a/1b clinical trials beginning April 2021 will assess the safety and tolerability of ZYUS’ lead drug product candidate in healthy adult participants ZYUS Life...
Oregon Oncology Specialists Integrates AI Clinical Trial Screening
Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform, VIPER™, into their...
AI and Systems Biology Leader My Intelligent Machines Secures $5M
My Intelligent Machines Inc. (“MIMs”), a leader in artificial intelligence and systems biology, today announced that it has completed an equity financing of $5 million....
Omada Health Launches Physician-Guided Care Program
First-of-its Kind Integrated Platform to Further Support Members with Chronic Conditions Today Omada Health announced the launch of Physician-Guided Care for diabetes and hypertension, creating the first...